Не сдохни! Еда в борьбе за жизнь

22
18
20
22
24
26
28
30

‹‹93››. Eskenazi B, Chevrier J, Rauch SA, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121(2):257–62.

‹‹94››. Schecter A, Pápke O, Harris TR, et al. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect. 2006;114(10):1515–20.

‹‹95››. Fraser AJ, Webster TF, McClean MD. Diet contributes significantly to the body burden of PBDEs in the general U.S. population. Environ Health Perspect. 2009;117(10):1520–5.

‹‹96››. Schecter A, Harris TR, Papke O, Tunga KC, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006;88(1):107–12.

‹‹97››. Huwe JK, West M. Polybrominated diphenyl ethers in U.S. meat and poultry from two statistically designed surveys showing trends and levels from 2002 to 2008. J Agric Food Chem. 2011; 59(10):5428–34.

‹‹98››. Dickman MD, Leung CK, Leong MK. Hong Kong male subfertility links to mercury in human hair and fish. Sci Total Environ. 1998;214:165–74.

‹‹99››. Srikumar TS, Johansson GK, Ockerman PA, Gustafsson JA, Akesson B. Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo. Am J Clin Nutr. 1992; 55(4):885–90.

‹‹100››. Wimmerová S, Lancz K, Tihányi J, et al. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011;82(5):687–91.

‹‹101››. Parkinson J. An Essay on the Shaking Palsy. London: Whittingham and Rowland for Sherwood, Neely and Jones, 1817:7.

‹‹102››. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57(3):456–62.

‹‹103››. Ueki A, Otsuka M. Life style risks of Parkinson’s disease: association between decreased water intake and constipation. J Neurol. 2004;251 Suppl 7:vII18–23.

‹‹104››. Gao X, Chen H, Schwarzschild MA, Ascherio A. A prospective study of bowel movement frequency and risk of Parkinson’s disease. Am J Epidemiol. 2011;174(5):546–51.

‹‹105››. Kamel F. Epidemiology. Paths from pesticides to Parkinson’s. Science. 2013;341(6147): 722–3.

‹‹106››. Barnhill LM, Bronstein JM. Pesticides and Parkinson’s disease: is it in your genes? Neurodegener Dis Manag. 2014;4(3):197–200.

‹‹107››. Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup Environ Med. 2014;71(4): 275–81.

‹‹108››. Narayan S, Liew Z, Paul K, et al. House hold organophosphorus pesticide use and Parkinson’s disease. Int J Epidemiol. 2013;42(5):1476–85.

‹‹109››. Liu X, Ma T, Qu B, Ji Y, Liu Z. Pesticide-induced gene mutations and Parkinson disease risk: a meta- analysis. Genet Test Mol Biomarkers. 2013;17(11):826–32.

‹‹110››. Lee SJ, Lim HS, Masliah E, Lee HJ. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res. 2011;70(4):339–48.

‹‹111››. Chorfa A, Lazizzera C, Betemps D, et al. A variety of pesticides trigger in vitro α-synuclein accumulation, a key event in Parkinson’s disease. Arch Toxicol. 2014.

‹‹112››. Dunnett SB, Bjorklund SBA. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999;399(6738 Suppl):A32–9.